Insulin pump therapy in transient neonatal diabetes mellitus
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Neonatal diabetes mellitus (NDM) is a rare disease requiring insulin treatment. Its treatment is primarily focused on maintaining adequate glycemic control and avoiding hypoglycemia. Although insulin pump therapy is frequently administered to adults and children, there is no consensus on the use of insulin pumps in NDM. A 10 day-old female infant was referred to us with intrauterine growth retardation and poor weight gain. Hyperglycemia was noted, and continuous intravenous insulin infusion was initiated. However, the patient’s serum glucose levels fluctuated widely,and maintaining the intravenous route became difficult within the following weeks. Continuous subcutaneous insulin infusion with an insulin pump was introduced on the twenty-fifth day of life, and good glycemic control was achieved without any notable adverse effects including hypoglycemia. We suggest that the insulin pump is a safe and effective mode for treating NDM and its early adoption may shorten the length of hospital stays in patients with NDM.
Abstract
Neonatal diabetes mellitus (NDM) is a rare disease requiring insulin treatment. Its treatment is primarily focused on maintaining adequate glycemic control and avoiding hypoglycemia. Although insulin pump therapy is frequently administered to adults and children, there is no consensus on the use of insulin pumps in NDM. A 10 day-old female infant was referred to us with intrauterine growth retardation and poor weight gain. Hyperglycemia was noted, and continuous intravenous insulin infusion was initiated. However, the patient’s serum glucose levels fluctuated widely,and maintaining the intravenous route became difficult within the following weeks. Continuous subcutaneous insulin infusion with an insulin pump was introduced on the twenty-fifth day of life, and good glycemic control was achieved without any notable adverse effects including hypoglycemia. We suggest that the insulin pump is a safe and effective mode for treating NDM and its early adoption may shorten the length of hospital stays in patients with NDM.
참고문헌 (16)
- von Muhlendahl KE, "Long-term course of neonatal diabetes", N Engl J Med, 333, pp.704~708 (1995)
- Polak M, "Neonatal diabetes mellitus: a disease linked to multiple mechanisms", Orphanet J Rare Dis, 2, pp.12~ (2007)
- Burns CM, "Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia", Pediatrics, 122, pp.65~74 (2008)
- Bharucha T, "Neonatal diabetes mellitus: Insulin pump as an alternative management strategy", J Paediatr Child Health, 41, pp.522~526 (2005)
- Wintergerst KA, "Continuous subcutaneous insulin infusion in neonatal diabetes mellitus", Pediatr Diabetes, 5, pp.202~206 (2004)
- "Diabetes mellitus, 6q24-related transient neonatal" (2005)[URL]
- Gloyn AL, "Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes", N Engl J Med, 350, pp.1838~1849 (2004)
- Vaxillaire M, "Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients", Diabetes, 53, pp.2719~2722 (2004)
- Babenko AP, "Activating mutations in the ABCC8 gene in neonatal diabetes mellitus", N Engl J Med, 355, pp.456~466 (2006)
- Temple IK, "Transient neonatal diabetes, a disorder of imprinting", J Med Genet, 39, pp.872~875 (2002)
- Docherty LE, "Further refinement of the critical minimal genetic region for the imprinting disorder 6q24 transient neonatal diabetes", Diabetologia, 53, pp.2347~2351 (2010)
- Sindelka G, "Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects", Diabetologia, 37, pp.377~380 (1994)
- Mecklenburg RS, "Long-term metabolic control with insulin pump therapy: report of experience with 127 patients", N Engl J Med, 313, pp.465~468 (1985)
- Shalitin S, "The use of insulin pump therapy in the pediatric age group", Horm Res, 70, pp.14~21 (2008)
- Weinzimer SA, "Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool-aged children with type 1 diabetes", Pediatr Diabetes, 7(4), pp.15~19 (2006)
- Tubiana-Rufi N., "Insulin pump therapy in neonatal diabetes", Endocr Dev, 12, pp.67~74 (2007)